… To test whether vaccination with synthetic peptides leads to protection against Ad5El -expressing
tumor cells, we vaccinated mice SC with a low dose of the Ad5E1 B peptide. This …

… of the Ad5E1 peptide vaccine either through incorporation of the peptides into liposomes or
… through peptide vaccination in a clinical setting, we set out to define vaccine formulations …

… outgrowth of Ad5ElAexpressing tumor cells in normal immunocompetent mice. The inhibitory
effects of peptide vaccination … than tolerance and tumor outgrowth. Our results indicate that …

… tumor outgrowth associated with peptide-induced tolerance (7, 8). However, the detailed
mechanism(s) for tolerance/activation induction by peptide vaccinations … -1 expressing tumors …

… (CTL) epitope-based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa
49–57 elicit protection against outgrowth of HPV 16-transformed tumor cells (C3 cells) in B6 mice…

… Application of the CSF-1R inhibitor alone did not lead to any change in tumor outgrowth.
Depletion of intratumoral macrophages by PLX3397 resulted in survival curves that were …

… and that these T cell responses can reduce tumor outgrowth (14). Here, we compare the …
peptide is sufficient to induce long-term CD8 + T cell responses and to inhibit tumor outgrowth. …

… tumor-associated antigen (TAA) gene in the early 1990s,1 the concept of peptide vaccination
… highly effective in protecting vaccinated mice from the outgrowth of syngeneic gliomas or …

… Our vaccine regimen also significantly delayed the outgrowth of mammary carcinomas in …
To evaluate TCR specificity and functional status of Th infiltrating tumors in our vaccinated triple …

… As a result, a broadened repertoire of anti-tumor effector T cells may then target tumor
lesions and prevent the outgrowth of single or limited “antigen-loss” tumor variants (8,9). …